Data protection Impressum

Digital Health

Swissmedic, Switzerland's national regulatory authority for therapeutic products, has strengthened its role in the global healthcare landscape through strategic collaborations and innovations in regulatory science. From cross-border initiatives to advances in digital transformation, Swissmedic is positioning itself as a leader in efficient, high-quality regulatory processes, providing Swiss patients with safe and timely access to cutting-edge therapies.

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics

11 November 2024

The 2024 MassChallenge Switzerland Awards recognized four Swiss start-ups among its top winners, including EPFL spin-off Myriad Optics, which received the CHF 80,000 Platinum Award for its pathogen detection technology.

MassChallenge Switzerland 2024 Awards recognizes innovative Western Switzerland start-ups

4 November 2024

PeriVision, a Bern-based start-up, has received CE Marking for its VisionOne device, allowing it to be sold throughout Europe.

PeriVision receives CE marking for its VisionOne glaucoma diagnostics device

4 November 2024

Ikerian has raised USD 8 million in Series B funding to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics. Lead investor Sanoptis has entered a strategic partnership to distribute the platform across its European network.

Ikerian secures USD 8 million and a strategic partnership with Sanoptis

29 October 2024

Distalmotion has received FDA approval for its Dexter Surgical Robot, allowing it to enter the U.S. outpatient market.

Distalmotion secures FDA approval for its Dexter surgical robot

29 October 2024

The canton of Fribourg, together with the Banque Cantonale de Fribourg (BCF), has revealed the nine finalists of the prestigious IFF (Innovation Fribourg Freiburg) Awards.

Business environment

Fribourg unveils nine finalists for the 2024-2025 IFF Innovation Awards

15 October 2024

machineMD has received EU-MDR Class IIa certification for its neos™ neuro-ophthalmic diagnostic device, setting a new standard for eye movement and pupil function assessment in neurology and ophthalmology.

machineMD’s neos receives EU-MDR Class IIa Certification to advance neuro-ophthalmic diagnostics

14 October 2024

Atinary Technologies and Snapdragon Chemistry, a Cambrex company, have announced a strategic collaboration to integrate AI-driven process optimization technology with advanced pharmaceutical development capabilities, aiming to revolutionize drug development.

Atinary Technologies and Snapdragon Chemistry partner to optimize drug development with AI

9 October 2024

PeriVision, in collaboration with Inselspital and the University of Bern, has received CHF 1.1 million to develop novel, AI-driven eye tests for retinal diseases like age-related macular degeneration and diabetic retinopathy.

PeriVision secures CHF 1.1 million grant for retinal disease research

1 October 2024

Neo Medical has raised USD 68 million in a Series B financing round to accelerate the global growth of its AI-driven spine surgery solutions, with a focus on the US market.

Neo Medical secures USD 68 million to expand its AI-powered spine surgery platform

24 September 2024

1 2 3 4 5 6 7 8 9 10 … 14